Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer

Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer ( Prof Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
21 Feb 2022

Pandemic strategising for cancer hospital stockpiles

Prof Richard Sullivan and Dr Aasim Yusuf
Pandemic strategising for cancer hospital stockpiles ( Prof Richard Sullivan and Dr Aasim Yusuf )
17 Feb 2022

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly round up for February 7th - 13th, 2022 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
17 Feb 2022

Cancer care in Turkey: Paediatric oncology during COVID-19 and palliative care

Prof Richard Sullivan and Prof Tezer Kutluk
Cancer care in Turkey: Paediatric oncology during COVID-19 and palliative care ( Prof Richard Sullivan and Prof Tezer Kutluk )
11 Feb 2022

Eye metastasis in breast cancer: Case report and review of literature

Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt
Eye metastasis in breast cancer: Case report and review of literature ( Dr Ereny Samwel Poles Saad - Assiut University, Asyut, Egypt )
10 Feb 2022

Update on the new EUSOMA quality indicators for breast cancer

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
Update on the new EUSOMA quality indicators for breast cancer ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022

The optimal approach after neoadjuvant treatment: The Lucerne toolbox

Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal
The optimal approach after neoadjuvant treatment: The Lucerne toolbox ( Prof Maria Cardoso - Champalimaud Foundation, Lisbon, Portugal )
3 Feb 2022

Lung cancer in India

Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India
Lung cancer in India ( Dr Krishnamani Kalpathi - American Oncology Institute, Hyderabad, India )
3 Feb 2022

The global impact of the FDA's changing approval standards

Dr Bishal Gyawali - Queen's University, Kingston, Canada
The global impact of the FDA's changing approval standards ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
2 Feb 2022

Tumour agnostic treatments in GI cancer

Dr Nicola Normanno and Dr Katja Schmitz
Tumour agnostic treatments in GI cancer ( Dr Nicola Normanno and Dr Katja Schmitz )
1 Feb 2022

ecancer-AORTIC special issue on cancer research training in Africa

Dr Solomon Rotimi - Covenant University, Ota, Nigeria
ecancer-AORTIC special issue on cancer research training in Africa ( Dr Solomon Rotimi - Covenant University, Ota, Nigeria )
27 Jan 2022

Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs placebo for early-stage TNBC

Prof Peter Schmid - Queen Mary University of London, London, United Kingdom
Neoadjuvant pembro + chemo vs placebo + chemo, followed by adjuvant pembro vs placebo for early-stage TNBC ( Prof Peter Schmid - Queen Mary University of London, London, United Kingdom )
27 Jan 2022